Ramirez, Teodoro Cesar Y.
HRN: 23-20-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
CEFAZOLIN 1GM (VIAL)
06/21/2023
06/28/2023
PO
500mg
Q6h
ROI
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes